Latest news with #ECR2025
Yahoo
23-03-2025
- Health
- Yahoo
Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence
CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA breast cancer risk model. A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR 2025. Volpara density now integrated into BOADICEA breast cancer risk model Volpara volumetric breast density assessment is now a validated input to the newly released version of the BOADICEA breast cancer risk model. This marks a significant milestone, as Volpara density is now integrated into two different breast cancer risk models—Tyrer-Cuzick and BOADICEA, sometimes referred to as IBIS or CanRisk, respectively. Any Volpara customers can use their Volpara density information via CanRisk today. CanRisk is endorsed by international societies and guidelines for use in Australia, the EU, the UK, the US, and Canada. Studies have shown the use of Volpara density in BOADICEA to improve model accuracy compared to using BI-RADS density categories, enhancing breast cancer risk assessment capabilities for healthcare providers worldwide. A record-high 21 Lunit and Volpara research abstracts at ECR 2025 At the European Congress of Radiology (ECR) 2025, Lunit and Volpara's solutions were featured in a record-high 21 independent research abstracts. This milestone highlights the growing impact of AI-driven breast health solutions in the global radiology community, reinforcing Volpara's and Lunit's commitment to advancing cancer detection and patient care through innovation and scientific research. About Volpara Health Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 3,500 facilities by more than 9,500 technologists worldwide. Volpara's software impacts nearly 18M patients, supports over 3.6M annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms with optimal positioning, compression, and dose. Volpara software also streamlines operations to ease compliance and accreditation. Volpara, a Lunit company, is headquartered in Wellington, New Zealand, and has an office in Seattle. Volpara is the trusted partner of leading healthcare institutions globally. For more information, visit Volpara Media Contact: Andrew Thompson-YoungClarity Quest Andrew@ Logo - View original content: SOURCE Volpara Health
Yahoo
26-02-2025
- Health
- Yahoo
MROpenEVO at ECR 2025 with an AI-ready upgrade for further enhanced image quality and faster examinations; new system soon available in Georgia
GENOA, Italy, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Unlocking the future of joint and spine imaging with the Latest Evolution of MROpenEvo: the only truly open MRI System at ECR 2025. Thanks to the optimization of key technical features, the latest version of the helium-free, MgB2-based MRI scanner delivers exceptional image quality while reducing scan times by up to 50%. Discover the innovative features of MROpenEvo, a groundbreaking MRI system specifically designed for joint, neuro, and spine imaging. It offers ample space for children, larger patients, and individuals with claustrophobia, ensuring comfort for all. The new image acquisition algorithm, based on the 'compressed sensing' technique, combines parallel imaging with sparse data sampling and iterative reconstruction. This combination leads to faster scan times and enhanced resolution. The 'compressed sensing' technique is applicable to both 2D and 3D sequences across all anatomies. In the meantime, the patient centric design MRI system developed by ASG Superconductors arrives in another new country: MROpenEvo will be shortly available in Georgia @ Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic. Prof. Giorgi Ingorokva declared: 'I am proud announcing that our hospital will be the first clinic in Georgia to install the groundbreaking Open MRI system. It will enhance diagnostic capabilities and improve patient care in the region.' Nowadays MROpen Evo is available in USA, Canada, UK, Italy, Portugal, Kuwait, and the innovative MgB2 superconducting technology – the key element driving the unique and distinctive open design - has reached over 2.5 million hours of operation. Join us at ECR2025 in Vienna, Hall X4, Booth 410, to experience MROpen Evo with our experts and discover how this innovative and unparalleled MRI system can enhance your practice. A Media Snippet accompanying this announcement is available by clicking on this link. Contact: Silvia Frigato Luca Pezzonilpezzoni@ in to access your portfolio
Associated Press
21-02-2025
- Business
- Associated Press
Bracco and the European Society of Radiology build on long-standing partnership at ECR 2025 through new campaign to advance innovative and sustainable approaches in radiology
Bracco will present an immersive experience at its booth to educate congress attendees on the importance of corporate commitment to sustainability and how its MR imaging portfolio contributes to the progress of sustainable radiology. Bracco will reinforce its commitment to deepening expertise within the radiology community through presentations, a symposium, and open sessions. MILAN, Feb. 21, 2025 /PRNewswire/ -- Bracco, a world leader in diagnostic imaging, announced today that it will showcase an innovative and immersive experience that brings the concept of sustainability to life and expands on 'Planet Radiology' – a campaign launched by the European Society of Radiology (ESR), a nonprofit professional organization dedicated to strengthening and unifying European radiology, at the European Congress of Radiology, taking place in Vienna from February 26 to March 2. In response to the ECR's campaign, Bracco has curated an experience for all congress attendees (Foyer E, Level 0, ACV) titled 'Our Journey to the Future Continues Today, Together, for a Sustainable Tomorrow.' The experience will provide a roadmap to sustainability in medical imaging and highlight technological advances that are transforming medical outcomes and improving patient lives. Specifically, attendees will encounter: 3D-digital pillars featuring statistics for how Bracco's efforts have helped reduce the environmental impact in radiology. Product spotlights demonstrating how Bracco products have specifically been designed to contribute to greater sustainability. An immersive Bracco Dome in which attendees can discover more about Bracco's end-of-life management projects, which are focused on ensuring the proper recycling and disposal of materials used in imaging procedures and are part of Bracco's comprehensive strategy to reduce the environmental footprint of radiology, from production to post-use. Click here for more information about specific presentations within the Dome. 'At Bracco, sustainability is integral to our everyday lifework because we believe that a healthy planet and society create the foundation for healthy people,' said Fulvio Renoldi Bracco, CEO of Bracco Imaging. 'Our vision extends to every part of what we do – from developing an innovative gadolinium-based contrast agent (GBCA) that uses less gadolinium compared to other currently approved macrocyclic GBCAs in their standard recommended doses, to recovering iodinated contrast media, to creating sustainable packaging initiatives that eliminate tertiary cardboard.' 'At ECR 2025, we wish to inspire a more sustainable approach to medical imaging,' said Andrea Rockall, ECR 2025 President. 'It is amazing to see other companies, like Bracco, championing and amplifying this message through a variety of initiatives, many of which we look forward to hearing more about at the congress.' Bracco will also host a series of educational sessions in collaboration with the ESR to advance the field of radiology, including a symposium, open-forum sessions, and an educational event. These sessions will further underline Bracco's commitment to sustainability, with expert-led discussions on the role of artificial intelligence in sustainability, optimizing dosing protocols and contrast management, integrating sustainable practices into daily radiology workflows, and the importance of empowering the next generation of radiologists. Highlights include: AI & Sustainability in radiology: an industry partner perspective on contrast optimization; Moderator: Amy King; Wednesday, February 26, 11.30 – 12.15, Open Forum Area, Foyer E, ACV Level 0. Redefining excellence in contrast-enhanced MRI: the benefits of gadopiclenol, moderated by Francesco Sardanelli. As part of this discussion, don't miss Safety and sustainability: evaluating the impact of reduced dose gadopiclenol, presented by Alberto Spinazzi, which will delve into how gadopiclenol enables dose reduction while enhancing both patient safety and environmental sustainability. Thursday, February 27, 12.30 – 13.00, Room N – ACV Level 1. Bracco and ESR: Young Clubs Take the Lead; Moderator: Federica Vernuccio; Thursday, February 27, 17.30 – 19.30, Room N – AVC Level 1. Photon counting CT and high iodine concentration: a clinical case review; Moderator: Pietro Spagnolo; Friday, February 28, 10.15 – 11.00, Open Forum Area, Foyer E, ACV Level 0. Click here for additional information on the Bracco program at ECR 2025. MEDIA CONTACTS Bracco media contact Carolina Bargoni Bracco Imaging, Communications Director [email protected] D: +39 347 5397738 European Society of Radiology contact David Zizka ESR, Director of Communications About Bracco Imaging Bracco Imaging S.p.A. ('Bracco Imaging'), part of the Bracco Group, is an innovative world leader delivering end-to-end products and solutions through its comprehensive portfolio across diagnostic imaging modalities. Headquartered in Milan, Italy, Bracco Imaging's purpose is to improve people's lives by shaping the future of prevention and precision diagnostic imaging. The Bracco Imaging portfolio includes products and solutions for all key diagnostic imaging modalities: X-ray imaging, magnetic resonance imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel PET imaging agents. Bracco Imaging has approximately 3,800 employees and operates in more than 100 markets globally. Bracco Imaging has a well-skilled and innovative Research and Development (R&D) organization with an efficient process-oriented approach and track record in the diagnostic imaging industry. R&D activities are in four centers based in Italy, Switzerland, the United Kingdom and the United States. To learn more about Bracco Imaging, visit About the European Congress of Radiology The ECR is the annual meeting of the European Society of Radiology (ESR), which represents more than 130,000 members from 186 countries worldwide. The ECR is one of the largest medical congresses in the world, attracting thousands of congress participants each year. With hundreds of companies showcasing their products at its technical exhibition, it is also one of the largest medical exhibitions in Europe.
